Application of Vishaghna Chikitsa in the management of Loota Visha (spider poisoning)- A case report
DOI:
https://doi.org/10.70066/jahm.v11i1.606Keywords:
loota ayurveda spider vishaAbstract
Visha is classified into Sthavar and Jangam. Sthavar visha includes Vatsnabha, Erand, Kupilu, etc and Jangam visha includes snakes, insects, spider etc. Loota visha is explained in detail in Ayurveda treatises. Spiders are anthropoids. There are various species of spiders in India. Spider bites are uncommon in India, and rarely produce fatal symptoms. The severity of envenomation varies according to species, dose, and duration of poisoning. Neurotoxic and cytotoxic are the two main components of spider venom. A female patient of 32 years came with complaints of Vesicular skin lesions, Pain, and Itching on her right elbow for four days. The case was diagnosed as Loota Visha and was effectively managed by adopting Vishaghna Chikitsa principles.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 DR KOMAL JADHAV

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.